ArticleOncoTargets and therapy2019

Frequency and clinical features of BRAF mutations among patients with stage III/IV lung adenocarcinoma without EGFR/ALK aberrations.

Ho Cheol Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.